Key Record Dates
ClinicalTrials.gov Identifier: | NCT03396445 |
---|---|
Brief Title: | Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) |
First Submitted : | January 4, 2018 |
First Submitted that Met QC Criteria : | January 4, 2018 |
First Posted : | January 11, 2018 |
Last Update Submitted that Met QC Criteria : | April 10, 2023 |
Last Update Posted : | April 11, 2023 |